Serum Institute of India and US-based Novavax signed an agreement for supply of the Novavax COVID-19 vaccines in India. The Institute was located at .....

2020

Please wait while the activity loads.
If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled.

If loading fails, click here to try again

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]

Serum Institute of India and US-based Novavax signed an agreement for supply of the Novavax COVID-19 vaccines in India. The Institute was located at ____

A	Pune
B	Delhi
C	Bengaluru
D	Hyderabad

Explanation:

Detailed explanation-1: -Nuvaxovid (Novavax) is approved and available for use as a primary course in people aged 12 years and over. Novavax is approved and available for use as a booster in people aged 18 years and over. The TGA provisionally approved Novavax for use as a primary course in Australia on 20 January 2022.

Detailed explanation-2: -The FDA has authorized the emergency use of the Novavax COVID-19 Vaccine, Adjuvanted as a primary series to prevent COVID-19 in individuals 12 years of age and older and as a first booster dose in individuals 18 years of age and older under an EUA.

Detailed explanation-3: -Both COVISHIELD™ (manufactured by Serum Institute of India Pvt Ltd) and COVID-19 Vaccine AstraZeneca (manufactured by AstraZeneca) are ChAdOx1 nCoV- 19 Corona Virus Vaccines (Recombinant).

Detailed explanation-4: -The vaccine is authorized for emergency use to provide: A two-dose primary series to individuals 12 years of age and older.

There is 1 question to complete.